PRESTIGE BIOPHARMA 프레스티지바이오파마 Prestigebiopharma

Innovation for Life

Developing Innovative drugs, Biosimilars, Platforms, and Diagnostic technologies to improve lives.

Advancing antibody drugs and biosimilars to address unmet medical needs.

Improving patient access through cost-effective, high-quality biosimilars.

PRESTIGE BIOPHARMA

PRESTIGE BIOPHARMA IDC

PRESTIGE BIOLOGICS

7

Beyond technological discovery, expanding access to care for patients around the world

Innovative Drug

Development of First-in-Class therapeutics for unmet diseases

Biosimilar

Prominent Biosimilars pipelines for accelerating market access

Platform Technology

A drug delivery platform that enhances treatment convenience

Diagnostics

Diagnostics for Pancreatic cancer by detecting PAUF

Prestige News

Total 78

Number	Thumbnail	Title	Author	Date	Votes	Views
8		Prestige Biopharma Identifies New Biomarker for Pancreatic Cancer Treatment we******** \| 2022.10.05 \| Votes 0 \| Views 1351	we********	2022.10.05	0	1351
7		Prestige Biopharma Receives FDA Approval for Phase 1/2a Trial of Pancreatic Cancer Drug PBP1510 김** \| 2022.06.27 \| Votes 0 \| Views 1753	김**	2022.06.27	0	1753
6		Prestige Biopharma announces International Non-proprietary Name for PBP1510 김** \| 2022.05.31 \| Votes 0 \| Views 1972	김**	2022.05.31	0	1972
5		Prestige Biopharma Wins “Bioprocessing Excellence in SEA” at Asia-Pacific Bioprocessing Awards 2022 김** \| 2022.04.01 \| Votes 0 \| Views 1347	김**	2022.04.01	0	1347
4		Prestige Biopharma Breaks Ground on R&D Center in Busan 김** \| 2021.12.20 \| Votes 0 \| Views 1120	김**	2021.12.20	0	1120
3		Prestige Biopharma Invests USD 110 Million in Korean Subsidiary 김** \| 2021.09.14 \| Votes 0 \| Views 2019	김**	2021.09.14	0	2019
2		Prestige Biologics to Be Listed on KOSDAQ on March 11, 2021 김** \| 2021.03.10 \| Votes 0 \| Views 1248	김**	2021.03.10	0	1248
1		Prestige Biopharma Debuts on KOSPI on March 5, 2021 김** \| 2021.02.08 \| Votes 0 \| Views 1603	김**	2021.02.08	0	1603

Read Prestige news >>